Aetion® Publishes Screening Tool to Identify Candidate Programs for Using Real-World Evidence to Support Effectiveness Claims in FDA Applications in Peer-Reviewed Journal
SURF intends to help sponsors make an initial feasibility assessment for using real-world data (RWD) to provide substantial evidence of effectiveness to support a U.S. Food and Drug Administration (FDA) approval.
- SURF intends to help sponsors make an initial feasibility assessment for using real-world data (RWD) to provide substantial evidence of effectiveness to support a U.S. Food and Drug Administration (FDA) approval.
- In recent years, FDA has made considerable progress in advancing its RWE program.
- "The SURF tool is based on Aetion's experience, and our review of FDA guidance and RWE uses in Agency approvals.
- To learn more about how Aetion can support your business leaders with using RWE in regulatory applications, please visit https://www.aetion.com to request a meeting today.